St. Peters, MO, United States of America

Gary A DeCrescenzo

Average Co-Inventor Count = 6.7

ph-index = 17

Forward Citations = 1,049(Granted Patents)

Forward Citations (Not Self Cited) = 741(Sep 21, 2024)

DiyaCoin DiyaCoin 0.18 

Inventors with similar research interests:


Location History:

  • Dardeene Prairie, MO (US) (2005)
  • St. Charles, MO (US) (2000 - 2006)
  • St. Peters, MO (US) (1991 - 2012)


Years Active: 1991-2012

where 'Filed Patents' based on already Granted Patents

139 patents (USPTO):

Title: The Accomplishments of Gary A DeCrescenzo in Innovations and Patents

Introduction:

Gary A DeCrescenzo, a dedicated inventor and innovator from St. Peters, MO, has made remarkable contributions to the field of retroviral protease inhibitors. With an impressive count of 136 patents, DeCrescenzo's work has greatly impacted the development of treatments for HIV protease. This article highlights his latest patents, career highlights, and collaborations.

Latest Patents:

DeCrescenzo's latest groundbreaking patents include the α- and β-amino acid hydroxyethylamino sulfonamides, which have demonstrated efficacy as retroviral protease inhibitors, specifically as inhibitors of HIV protease. These compounds offer potential new avenues for the treatment of HIV, representing significant advancements in the field of antiretroviral therapy.

Career Highlights:

Throughout his career, DeCrescenzo has worked with esteemed companies such as G.D. Searle & Company (now part of Pfizer) and Monsanto Corporation (now Bayer Crop Science). His contributions have played an instrumental role in shaping the future of pharmaceutical sciences.

Collaborations:

DeCrescenzo has had the privilege of collaborating with exceptional individuals in his field. Notably, he has worked alongside Daniel P Getman and Michael L Vazquez, both esteemed professionals with vast knowledge and expertise in the pharmaceutical and biochemistry domains. These collaborations have fostered an environment of innovation and provided valuable insights into the development of retroviral protease inhibitors.

Conclusion:

Gary A DeCrescenzo's numerous patents and outstanding contributions to the field of retroviral protease inhibitors exemplify his dedication to innovation and improving healthcare outcomes. The α- and β-amino acid hydroxyethylamino sulfonamides he developed demonstrate immense potential for the treatment of HIV, furthering advancements in antiretroviral therapy. DeCrescenzo's career highlights and collaborations highlight his commitment to advancing the field and his collaborative spirit within the scientific community.

For more information about Gary A DeCrescenzo, his patents, and other notable inventors and innovations, visit our website, idiyas.com.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…